Vanguard Group Inc Scynexis Inc Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SCYX
# of Institutions
57Shares Held
15.4MCall Options Held
0Put Options Held
12.9K-
Federated Hermes, Inc. Pittsburgh, PA4.21MShares$8.43 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$4.47 Million0.4% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$2.9 Million0.08% of portfolio
-
Amh Equity LTD660KShares$1.32 Million1.0% of portfolio
-
Bank Of America Corp Charlotte, NC582KShares$1.16 Million0.0% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $65.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...